The lawyers at Saiontz & Kirk are no longer accepting new claims for investors in Medical Capital Notes. This page is provided for information purposes only.
Potential securities fraud claims were being reviewed for investors throughout the United States who were sold Medical Capital Notes on or after September 18, 2006.
MEDICAL CAPITAL INVESTMENT FRAUD PROBLEMS
Investors were sold Medical Capital notes as private investments in account receivables of medical providers. However, the Securities Exchange Commission (SEC) has charged Medical Capital Holdings, Inc. with fraud involving the sale of these private investment notes, and many brokerage firms that recommended and sold these notes may be liable for losses suffered by investors.
The SEC has indicated that investors were defrauded of millions of dollars, including a number of questionable transactions and investments that had nothing to do with the medical receivables business. Medical Capital allegedly conducted transactions with itself, swapped old receivables to new investment entities and overstated the value of some of its receivables.
Several brokerage firms violated federal securities laws by selling these notes under false and misleading prospectuses, which provided misinformation about the track records and qualifications of the company managing the investments and the overall risk associated with Medical Capital Notes.
New cases are no longer being accepted by Saiontz & Kirk, P.A. This page is maintained for informational purposes only.
